KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2023 | $2,592 | -81.6% | 245 | -78.7% | 0.00% | -100.0% |
| Q1 2023 | $14,065 | +160.6% | 1,150 | +164.4% | 0.00% | +100.0% |
| Q4 2022 | $5,398 | -40.0% | 435 | -34.5% | 0.00% | -50.0% |
| Q3 2022 | $9,000 | -35.7% | 664 | -10.3% | 0.00% | 0.0% |
| Q2 2022 | $14,000 | +7.7% | 740 | -7.4% | 0.00% | 0.0% |
| Q1 2022 | $13,000 | -50.0% | 799 | -57.5% | 0.00% | -50.0% |
| Q4 2021 | $26,000 | +1200.0% | 1,878 | +1655.1% | 0.00% | +300.0% |
| Q3 2021 | $2,000 | 0.0% | 107 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 107 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $3,000 | 0.0% | 107 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $3,000 | 0.0% | 107 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,000 | +50.0% | 107 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | +100.0% | 107 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |